These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 39057926)
41. Botulinum toxin type A treatment of four cases of Wilson disease with lower limb dystonia: A prospective study. Cao Z; Rao R; Wu T; Chen S; Xing S; Han Y Toxicon; 2023 Jan; 221():106959. PubMed ID: 36343759 [TBL] [Abstract][Full Text] [Related]
42. The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A -- initial experiences. Barnes MP; Best D; Kidd L; Roberts B; Stark S; Weeks P; Whitaker J Eur J Neurol; 2005 Dec; 12(12):947-55. PubMed ID: 16324088 [TBL] [Abstract][Full Text] [Related]
43. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias. Rosales RL; Ng AR; Santos MM; Fernandez HH Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790 [TBL] [Abstract][Full Text] [Related]
44. Debunking the pathophysiological puzzle of dystonia--with special reference to botulinum toxin therapy. Kaňovský P; Rosales RL Parkinsonism Relat Disord; 2011 Nov; 17 Suppl 1():S11-4. PubMed ID: 21999889 [TBL] [Abstract][Full Text] [Related]
48. Botulinum toxin for motor disorders. Safarpour D; Jabbari B Handb Clin Neurol; 2023; 196():539-555. PubMed ID: 37620089 [TBL] [Abstract][Full Text] [Related]
49. Diagnostic and therapeutic recommendations in adult dystonia: a joint document by the Italian Society of Neurology, the Italian Academy for the Study of Parkinson's Disease and Movement Disorders, and the Italian Network on Botulinum Toxin. Romano M; Bagnato S; Altavista MC; Avanzino L; Belvisi D; Bologna M; Bono F; Carecchio M; Castagna A; Ceravolo R; Conte A; Cosentino G; Eleopra R; Ercoli T; Esposito M; Fabbrini G; Ferrazzano G; Lalli S; Mascia MM; Osio M; Pellicciari R; Petrucci S; Valente EM; Valentino F; Zappia M; Zibetti M; Girlanda P; Tinazzi M; Defazio G; Berardelli A Neurol Sci; 2022 Dec; 43(12):6929-6945. PubMed ID: 36190683 [TBL] [Abstract][Full Text] [Related]
50. Botulinum toxin treatment of occupational and focal hand dystonia. Karp BI Mov Disord; 2004 Mar; 19 Suppl 8():S116-9. PubMed ID: 15027063 [TBL] [Abstract][Full Text] [Related]
51. Treatment of focal dystonias with botulinum neurotoxin. Hallett M; Benecke R; Blitzer A; Comella CL Toxicon; 2009 Oct; 54(5):628-33. PubMed ID: 19103214 [TBL] [Abstract][Full Text] [Related]
53. Secondary dystonia in a botulinum toxin clinic: clinical characteristics, neuroanatomical substrate and comparison with idiopathic dystonia. Strader S; Rodnitzky RL; Gonzalez-Alegre P Parkinsonism Relat Disord; 2011 Dec; 17(10):749-52. PubMed ID: 21852177 [TBL] [Abstract][Full Text] [Related]
54. Vada maker's dystonia - A new task-specific focal dystonia. Cherian A; Divya KP Parkinsonism Relat Disord; 2020 Aug; 77():85-86. PubMed ID: 32653841 [No Abstract] [Full Text] [Related]
55. Botulinum Toxin A and Task-Specific Training for Hand Dystonia due to 5 Year Old Stroke. Masood T; Umar M J Coll Physicians Surg Pak; 2018 Mar; 28(3):S60-S62. PubMed ID: 29482711 [TBL] [Abstract][Full Text] [Related]
56. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part I): muscle afferent block versus botulinum toxin-A in cervical and limb dystonias. Rosales RL; Santos MM; Ng AR; Teleg R; Dantes M; Lee LV; Fernandez HH Int J Neurosci; 2011; 121 Suppl 1():35-43. PubMed ID: 21244305 [TBL] [Abstract][Full Text] [Related]
57. Botulinum toxin injections reduce associative plasticity in patients with primary dystonia. Kojovic M; Caronni A; Bologna M; Rothwell JC; Bhatia KP; Edwards MJ Mov Disord; 2011 Jun; 26(7):1282-9. PubMed ID: 21469207 [TBL] [Abstract][Full Text] [Related]
58. Electromyographic and Joint Kinematic Patterns in Runner's Dystonia. Ahmad OF; Ghosh P; Stanley C; Karp B; Hallett M; Lungu C; Alter K Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29677101 [TBL] [Abstract][Full Text] [Related]
59. Successful treatment of open jaw and jaw deviation dystonia with botulinum toxin using a simple intraoral approach. Moscovich M; Chen ZP; Rodriguez R J Clin Neurosci; 2015 Mar; 22(3):594-6. PubMed ID: 25541097 [TBL] [Abstract][Full Text] [Related]
60. Botulinum toxin injection to improve functional independence and to alleviate parenting stress in a child with advanced pantothenate kinase-associated neurodegeneration: A case report and literature review. Lin CI; Chen KL; Kuan TS; Lin SH; Lin WP; Lin YC Medicine (Baltimore); 2018 May; 97(20):e10709. PubMed ID: 29768338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]